S36ɳÁú»á

EN
S36ɳÁú»á - ÒªÍæ¾ÍÍæÉ³Áú»á S36ɳÁú»á - ÒªÍæ¾ÍÍæÉ³Áú»á
ÐÂÎÅÖÐÐÄ
2024-05-28
¸Éϸ°û»ò¿ªÆôÐÄË¥ÖÎÁÆÐÂʱ´ú£¬£¬£¬£¬£¬£¬Æê´ø¼ä³äÖʸÉϸ°ûÖÎÁÆÐÄË¥½øÈëÁÙ´²ÊÔÑé
ÎÒ¹úÏÖÔÚÐÄѪ¹Ü¼²²¡»¼ÕßÊýÄ¿´ï3.3ÒÚ£¬£¬£¬£¬£¬£¬ÆäÖÐÏ£ÍûΪÐÄÁ¦Ë¥½ß£¨¼òÂúÒâË¥£©Õß²¢²»ÓÐÊý£¬£¬£¬£¬£¬£¬Ô¼ÓÐ890ÍòÓàÃû»¼Õß±¥ÊÜÆä¿à£¬£¬£¬£¬£¬£¬5ÄêéæÃüÂÊÁè¼Ý50%¡£¡£¡£ÄÚ¡¢Íâ¿ÆµÄÒ©Îï¡¢Æð²«Æ÷¡¢ÐÄÔàÒÆÖ²µÈÏÖÐÐÖÎÁÆ·½·¨¾ù±£´æÒ»¶¨È±ÏÝ£¬£¬£¬£¬£¬£¬ÊÇ·ñÓÐÍ»ÆÆÐÔÐÂÁÆ·¨£¿£¿£¿¼ÇÕßÈÕǰ´ÓÉϺ£Êж«·½Ò½Ôº»ñϤ£¬£¬£¬£¬£¬£¬Óɹú¼Ò¸Éϸ°ûת»¯×ÊÔ´¿âÁÙ´²¼¶¸Éϸ°û¿âÈÏÕæÈË¡¢ÐÅÓÃÔº³¤ÁõÖÐÃñÍŶÓÑз¢µÄ¡°ÈËÆê´ø¼ä³äÖʸÉϸ°ûÖÎÁÆÐÄË¥×¢ÉäÒº¡±ÒѽøÈëIÆÚÁÙ´²ÊÔÑé½×¶Î£¬£¬£¬£¬£¬£¬ÕâÒ²ÊÇÎÒ¹úÔÚ¸ÃÁìÓòµÄÊ׿îÒ©Îï¡£¡£¡£
ÔĶÁ¸ü¶à
2024-05-24
¼ä³äÖʸÉϸ°ûÔÚÀà¹Ì´¼ÄÍÒ©¼±ÐÔÒÆÖ²ÎËÞÖ÷²¡ÖÎÁÆÖеÄDZÁ¦
ʹÓÃiPSϸ°ûÑÜÉúµÄ¼ä³äÖʸÉϸ°û£¨CYP-001£©ÖÎÁÆÀà¹Ì´¼ÄÍÒ©¼±ÐÔÒÆÖ²ÎËÞÖ÷²¡£¡£¡£¨GvHD£©ÔÚ2ÄêËæ·ÃÖÐÏÔʾ³öÇå¾²ÐÔ¡¢ÄÍÊÜÐÔºÍÒ»Á¬ÁÆÐ§¡£¡£¡£
ÔĶÁ¸ü¶à
2024-05-20
°¬×̲¡»¼ÕßÐÂÏ£Íû£¡ÎÒ¹úѧÕßÐû²¼CAR-Tϸ°ûÖÎÁư¬×̲¡ÁÙ´²ÊÔÑéÊý¾Ý
¿ËÈÕ£¬£¬£¬£¬£¬£¬¸´µ©´óѧÉϺ£¹«¹²ÎÀÉúÁÙ´²ÖÐÐÄÐ콨ÇàÑо¿Ô±¡¢ÕÅÏþÑàÑо¿Ô±¡¢ÕÅÈÊ·¼Ö÷ÈÎҽʦ£¬£¬£¬£¬£¬£¬µÚËľüÒ½´óÑ§ÌÆ¶¼Ò½ÔºËïÓÀÌνÌÊÚ¡¢¹ãÎ÷ÖÐÒ½Ò©´óѧÀä¾²½ÌÊÚµÈÔÚCell DiscoveryÆÚ¿¯½ÒÏþÁËÌâΪ¡°Efficacy and safety of novel multifunctional M10 CAR-T cells in HIV-1-infected patients: a phase I, multicenter, single-arm, open-label study ¡±µÄÑо¿ÂÛÎÄ¡£¡£¡£
ÔĶÁ¸ü¶à
2024-05-17
¡°´Ó0µ½1¡±µÄÖØ´óÍ»ÆÆ£¡½­ËÕÒ»Ò½Ôº½ÓÄÉ»ùÒòÖÎÁÆÈû¼ÕßÖØ»ñÌýÁ¦
¼ÇÕß´ÓÄϾ©¹ÄÂ¥Ò½Ôº¿ËÈÕÕÙ¿ªµÄ¡°¶úÁû»ùÒòÖÎÁÆÑо¿¡±ÐÂÎÅÐû²¼»áÉÏÏàʶµ½£¬£¬£¬£¬£¬£¬Ò»Ãû2ËêµÄÏÈÌìÐÔ¶úÁû»¼ÕßÔÚ½ÓÊܶúÁû»ùÒòÖÎÁÆÊÖÊõºóÌýÁ¦Ò»Á¬ÌáÉý£¬£¬£¬£¬£¬£¬²¿·ÖÖ¸±êÒÑ´ïÕý³£Ë®Æ½¡£¡£¡£
ÔĶÁ¸ü¶à
2024-05-16
һλʹÓÃCAR-TÖÎÁư×Ѫ²¡µÄ¶ùͯ»¼ÕßÒÑÎÞ°©ÉúÑÄ12Äê
¾ÝEmily Whitehead»ù½ð»á×îÐÂÐÂÎÅ£¬£¬£¬£¬£¬£¬Ò»Î»Ê¹ÓÃCAR-TÁÆ·¨ÖÎÁư×Ѫ²¡µÄ»¼Õß¡ª¡ªÏÖÄê19ËêµÄÃÀ¹úÅ®º¢EmilyÒÑÎÞ°©ÉúÑÄ12Äê¡£¡£¡£
ÔĶÁ¸ü¶à
2024-05-15
»ùÒòÖÎÁƻָ´Ê§´Ï¶ùͯÌýÁ¦£¬£¬£¬£¬£¬£¬¶úÁûÖÎÁƽøÈëÐÂʱ´ú
Ò»ÃûÍêȫʧ´ÏµÄÓ¢¹úÅ®º¢³ÉΪÌìÏÂÉÏÊ׸ö½ÓÊÜ¿ª´´ÐÔлùÒòÖÎÁÆÊÔÑéµÄÈË¡£¡£¡£ÏÖÔÚ£¬£¬£¬£¬£¬£¬ËýµÄÌýÁ¦ÒÑ»ñµÃÁ˻ָ´¡£¡£¡£¸ÃЧ¹ûÔÚ½üÆÚÓÚÃÀ¹ú°Í¶ûµÄĦ¾ÙÐеÄÃÀ¹ú»ùÒòÓëϸ°ûÖÎÁÆÑ§»á¾Û»áÉϱ»Ðû²¼¡£¡£¡£
ÔĶÁ¸ü¶à
2024-05-13
È˹¤ÖÇÄÜÉè¼ÆµÄ»ùÒò±à¼­¹¤¾ßÀ´ÁË
ÔÚһֱ̽Ë÷ÒÔǰδ֪µÄCRISPR»ùÒò±à¼­ÏµÍ³µÄÀú³ÌÖУ¬£¬£¬£¬£¬£¬Ñо¿Ö°Ô±´ÓÎÂȪ¡¢ÄàÌ¿ÕÓÔó¡¢·à±ãÉõÖÁËáÄÌÖÐÕ÷²ÉÖÖÖÖ΢ÉúÎï¡£¡£¡£ÏÖÔÚ£¬£¬£¬£¬£¬£¬ÓÉÓÚÌìÉúʽÈ˹¤ÖÇÄܵÄǰ½ø£¬£¬£¬£¬£¬£¬ËûÃÇ¿ÉÄÜÖ»Ð谴һϰ´Å¥¾Í¿ÉÒÔÉè¼Æ³öÕâЩϵͳ¡£¡£¡£ ¾Ý¡¶×ÔÈ»¡·±¨µÀ£¬£¬£¬£¬£¬£¬ÈÕǰ£¬£¬£¬£¬£¬£¬Ñо¿Ö°Ô±Ðû²¼ÁËËûÃÇÔõÑùʹÓÃÒ»ÖÖÃûΪÂѰ×ÖÊÓïÑÔÄ£×ÓµÄÌìÉúʽÈ˹¤ÖÇÄܹ¤¾ßÉè¼ÆCRISPR»ùÒò±à¼­ÂѰ×ÖʵÄϸ½Ú£¬£¬£¬£¬£¬£¬²¢Ö¤ÊµÆäÖÐһЩϵͳÈçÔ¤ÆÚÄÇÑùÊÂÇé¡£¡£¡£
ÔĶÁ¸ü¶à
2024-05-10
520λ¸´¾ÙÊÂÖÎÐÔѪҺ²¡»¼Õß»ñÐÂÉú£¬£¬£¬£¬£¬£¬Î人ЭºÍÒ½Ôº»ªÖÐÊ׿ªCAR-TÃÅÕï
¡°Ò»Õëɨ³ý°©Ï¸°û¡±²»ÊÇÃΣ¡»ªÖпƼ¼´óѧÁ¥ÊôЭºÍÒ½Ôº½«CAR-Tϸ°ûÃâÒßÖÎÁÆÊÖÒÕ´øµ½»¼ÕßÉí±ß¡£¡£¡£5ÔÂ8ÈÕ£¬£¬£¬£¬£¬£¬¸ÃÔºÔÚ»ªÖеØÇøÊ׸ö¿ªÉèCAR-TÃÅÕ£¬£¬£¬£¬£¬½«Óɶàѧ¿Æ×¨¼ÒΪѪ°©»¼ÕßÌṩ¸öÐÔ»¯¡¢¾«×¼»¯µÄÖÎÁƼƻ®¡£¡£¡£Ð­ºÍÒ½ÔºÔº³¤¡¢»ªÖпƼ¼´óѧѪҺ²¡Ñо¿ËùËù³¤¡¢ÖлªÒ½Ñ§»áѪҺѧ·Ö»áºòÈÎÖ÷ίºúÔ¥½ÌÊÚÏÈÈÝ£¬£¬£¬£¬£¬£¬×Ô2015ÄêÖÁ½ñ£¬£¬£¬£¬£¬£¬¸ÃԺΪ520λ¸´¾ÙÊÂÖÎÐÔѪҺ²¡»¼ÕßÍê³ÉCAR-TÖÎÁÆ£¬£¬£¬£¬£¬£¬×ÜÌ建½âÂÊ´ï90%ÒÔÉÏ£¬£¬£¬£¬£¬£¬Õâ±ê¼ÇןÃÔºµÄCAR-TÖÎÁÆÊÖÒÕÕûÌåµÖ´ï¹ú¼ÊÏȽøË®Æ½¡£¡£¡£
ÔĶÁ¸ü¶à
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿